Supplementary Figure 2. Kaplan Meier plot showing patients on insulin alone vs insulin and metformin
Kaplan-Meier plots comparing insulin alone users versus insulin and metformin users are shown.
There was no statistically significant difference, with small sample size (only 4 patients on insulin + metformin group and 30 patients on insulin alone group).
P=0.5071
P=0.7012 P=0.5334
Supplementary Figure 3. Kaplan Meier plot showing patients without insulin
Kaplan-Meier plots comparing metformin without insulin users (n=128) versus non-metformin without insulin users (n=164) are shown. We could confirm the trend toward better survival in metformin users compared to non-metformin users, even excluding insulin users. Even though the pvalue was more than 0.05, it might be due to small size of population since we subtracted the insulin users. Multivariable Cox proportional hazards model with time-dependent covariates, considering insulin use as one of the covariates, is shown in Table 3 . We have shown that cumulative metformin use prolonged survivals (RFS, CSS, and OS) even considering insulin usage. showed results with the same definition. We conducted Kaplan-Meier plot also with only counting recurrence-event, not death, to give additive information. Kaplan-Meier plot of recurrence-event only
(not death) free survival according to DM status was drawn, and significant less recurrence was found (Log-rank P-value = 0.006). Among DM patients, Kaplan-Meier plot of recurrence-event only free survival according to metformin use was drawn, and even-though no statistically significant difference was found among DM patients according to metformin use, there was trend toward less recurrence event to metformin group (Log-rank P-value = 0.12). It might be statistically significant if larger population was analyzed.
P=0.006 P=0.12

Supplementary Table 1. Pattern of recurrence among each groups
Site for the first relapse is described in the table, according to each group, among available 284 data out of total 323 recurrences. There was no statistically significant difference in distribution of first relapse site among three groups (non-DM vs. metformin DM vs. non-metformin DM) (P=0.325).
Distant metastasis was most common recurrence pattern, and loco-regional recurrence was the most rare recurrence pattern.
Supplementary Table 2. Pattern of recurrence according to stage
Site for the first relapse according to stage is described in the 
